NeuroPace (NPCE) Total Liabilities (2020 - 2026)

NeuroPace's Total Liabilities history runs 7 years deep, the most recent figure standing at $84.4 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 1.74% year-over-year to $84.4 million; the TTM figure through Mar 2026 stood at $84.4 million (down 1.74% YoY), while the FY2025 annual figure was $86.5 million, changed 0.12% from the prior year.
• Total Liabilities was $84.4 million for Q1 2026 at NeuroPace, down from $86.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $88.7 million in Q3 2025 to a low of $65.6 million in Q2 2022.
• Historically, Total Liabilities has averaged $81.9 million across 5 years, with a median of $84.5 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Total Liabilities surged 32.09% in 2022, then slipped 1.74% in 2026.
• A 5-year view of Total Liabilities shows it stood at $79.3 million in 2022, then gained by 9.67% to $87.0 million in 2023, then retreated by 0.42% to $86.6 million in 2024, then dropped by 0.12% to $86.5 million in 2025, then dropped by 2.42% to $84.4 million in 2026.
• The last three Total Liabilities figures came in at $84.4 million (Q1 2026), $86.5 million (Q4 2025), and $88.7 million (Q3 2025), per Business Quant data.